Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Hematology/Oncology

Inflammatory Breast Cancer

There is no time at which patients can be completely assured that the disease will not recur.
CME credit is no longer available for this conference.

Course Authors

Robert G. Lerner, M.D.

In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.

Release Date: 09/29/2002

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Describe the clinicopathologic entity of inflammatory breast cancer

  • Discuss the prognosis for women with inflammatory breast cancer

  • Explain the dramatic improvement in prognosis since the introduction of modern combined modality therapy

  • Discuss the availability of and controversy surrounding the use of autologous bone marrow transplantation for breast cancer.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Alcohol Abuse and Cancer

poses unique challenges for clinicians. This Cyberounds® will focus on the epidemiology, pathophysiology, clinical implications and management strategies for the comorbidity of AUD and cancer. The goal is to provide a comprehensive, clinically oriented overview that highlights the intricate relationship between these two conditions and the implications for patient care. …
Authors: Danilo De Gregorio, PharmD, Ph.D.
View Course
More

AML2

View Course
More

Emerging Treatments In Acute Myeloid Leukemia (AML)

Several investigational agents offer hope to patients with AML.
Authors: Mary-Elizabeth M. Percival, M.D., M.S. and Roland B. Walter, M.D., Ph.D., M.S.
View Course
More

Pro-State Challenge 2

View Course
More

Unexplained Bleeding in Hospitalized Patients

While some disorders are more readily apparent than others, not all bleeding is straightforward or has a readily identifiable cause.
Authors: Meera B. Chitlur, M.D.
View Course
More

Lung Cancer Chemoprevention

Despite advances in lung cancer chemotherapy, there is a pressing need for effective lung cancer chemoprevention beyond smoking cessation.
Authors: Robert L. Keith, M.D.
View Course
More